SLC5A2 and hydrops fetalis: However, this propensity score matching retrospective cohort study demonstrated that the early initiation of SGLT2 inhibitors in ACS complicated by new-onset AHF was associated with improved cardiovascular outcomes, driven mainly by HF hospitalization benefit.